Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TAK | ZTS | UTHR | NBIX | STVN |
| Company | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | United Therapeutic | Neurocrine Bioscienc | Stevanato Group S.P.A. |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 13.08 | 152.63 | 236.59 | 137.47 | 27.98 |
| High | 13.08 | 158.74 | 237.53 | 138.63 | 28.17 |
| Low | 13.01 | 152.63 | 233.64 | 135.17 | 27.35 |
| Last | 13.03 | 158.42 | 233.85 | 135.99 | 27.54 |
| Change | -0.04 | +5.06 | -2.10 | -1.77 | +0.02 |
| % Change | -0.31% | +3.30% | -0.89% | -1.28% | +0.07% |
| Volume | 1,213,474 | 5,236,457 | 369,600 | 717,500 | 335,568 |
| 20-Day Average Volume | 1,749,070 | 4,280,780 | 491,470 | 765,780 | 347,865 |
| Previous Close | 13.07 | 153.36 | 235.95 | 137.76 | 27.52 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.39 | 157.36 | 234.48 | 136.46 | 28.78 |
| 20-Day Raw Stochastic | 3.23% | 55.16% | 62.10% | 39.41% | 16.43% |
| 20-Day Relative Strength | 33.29% | 43.71% | 49.91% | 49.27% | 41.81% |
| Weighted Alpha | -22.33 | -14.57 | +3.13 | +35.60 | -3.35 |
| Today's Opinion | 100% Sell | 72% Sell | 64% Buy | 48% Buy | 56% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 80% Buy | 96% Buy | 56% Sell |
| Last Month's Opinion | 72% Sell | 40% Sell | 40% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.59% since 04/19/24 | +8.14% since 04/19/24 | -1.71% since 04/19/24 | +3.02% since 04/19/24 | +3.03% since 04/19/24 |
| Low | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 233.27 on 04/24/24 | 131.79 on 04/22/24 | 26.47 on 04/25/24 |
| High | 13.41 on 04/23/24 | 158.74 on 04/26/24 | 241.00 on 04/24/24 | 145.00 on 04/23/24 | 28.17 on 04/26/24 |
| 1-Month | |||||
| %Chg | -9.45% since 03/26/24 | -4.38% since 03/26/24 | -5.65% since 03/26/24 | -3.66% since 03/26/24 | -13.37% since 03/26/24 |
| Low | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 | 26.47 on 04/25/24 |
| High | 14.37 on 03/27/24 | 171.14 on 03/28/24 | 249.68 on 03/27/24 | 145.00 on 04/23/24 | 33.49 on 03/27/24 |
| 3-Month | |||||
| %Chg | -10.75% since 01/26/24 | -17.28% since 01/26/24 | +7.27% since 01/26/24 | -4.33% since 01/26/24 | -13.18% since 01/26/24 |
| Low | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 | 25.52 on 03/21/24 |
| High | 14.88 on 02/27/24 | 200.53 on 02/29/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 | 34.73 on 02/07/24 |
| 6-Month | |||||
| %Chg | -2.62% since 10/26/23 | +0.22% since 10/26/23 | +4.21% since 10/26/23 | +26.01% since 10/26/23 | -4.94% since 10/26/23 |
| Low | 13.01 on 04/26/24 | 144.80 on 04/22/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 | 23.00 on 11/01/23 |
| High | 15.07 on 01/12/24 | 201.92 on 12/14/23 | 258.31 on 12/14/23 | 148.37 on 03/21/24 | 34.73 on 02/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 41,364,172 | 70,140,576 | 11,103,569 | 13,708,084 | 8,133,261 |
| Shares Outstanding, K | 3,164,818 | 457,359 | 47,059 | 99,507 | 295,540 |
| Annual Sales | 29,803,340,000 | 8,544,000,000 | 2,327,500,000 | 1,887,100,000 | 1,174,680,000 |
| Annual Net Income | 2,345,930,000 | 2,344,000,000 | 984,800,000 | 249,700,000 | 157,620,000 |
| Last Quarter Sales | 7,556,070,000 | 2,213,000,000 | 614,700,000 | 515,200,000 | 345,420,000 |
| Last Quarter Net Income | 718,900,000 | 525,000,000 | 217,100,000 | 147,700,000 | 48,700,000 |
| 60-Month Beta | 0.53 | 0.85 | 0.52 | 0.25 | 0.70 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.51 on 02/01/24 | 1.24 on 02/13/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 | 0.19 on 03/07/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/01/24 | 05/01/24 | 05/02/24 |
| Most Recent Dividend | 0.261 on 09/28/23 | 0.432 on 04/18/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | 09/28/23 | 04/18/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 6.78 | 28.36 | 11.95 | 57.43 | 44.05 |